Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer-Associated Germline Pathogenic Variants in Mexico.
Fernanda Mesa-ChavezYanin Chavarri GuerraDione Aguilar-Y-MendezAndrea Becerril-GaitanBryan F Vaca-CartagenaAraceli Carrillo-BedoyaSalvador Santiesteban-GonzálezAlejandro Aranda-GutierrezAndrés Rodríguez-FaureDaniela Obregon-LealGregorio Quintero BeuloJose L Rodriguez-OlivaresMelina Miaja-AvilaJeffrey N WeitzelCynthia Villarreal GarzaPublished in: JCO global oncology (2024)
Despite the resource-constrained setting, relevant rates of RR measures and CT were observed. Targeted interventions to reduce out-of-pocket expenses and improve patient-physician communication and patients' understanding on carrier status are warranted to enhance the overall benefit of GCRA and ultimately improve the provision of patient-centered care to both carriers and their at-risk relatives.
Keyphrases
- end stage renal disease
- palliative care
- healthcare
- emergency department
- newly diagnosed
- primary care
- computed tomography
- prognostic factors
- chronic kidney disease
- peritoneal dialysis
- physical activity
- dna repair
- magnetic resonance
- copy number
- pain management
- quality improvement
- gene expression
- dna methylation
- patient reported outcomes
- contrast enhanced
- drug delivery
- dna damage
- young adults
- genome wide